NF-κB/MAPK-IN-1

Research use only, not for human use.

NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38.

NF-κB/MAPK-IN-1 (compound 11a) is a potent inhibitor of NF-κB and MAPK pathway. NF-κB/MAPK-IN-1 shows inhibitory activity against NO production, with an IC50 of 6.96 μM. NF-κB/MAPK-IN-1 suppresses LPS-induced iNOS, COX-2, ERΚ and P38 signaling activation. NF-κB/MAPK-IN-1 can prevent LPS induced inflammatory response in macrophages. NF-κB/MAPK-IN-1 can be used for rheumatoid arthritis (RA) research.

——

——

——

Apoptosis

NF-κB

NF-κB | MAPK

——

——

2413940-56-2

477.51

C27H27NO7

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (209.42 mM; Ultrasonic )

O(C1=C(C(C)=O)C=CC(OC)=C1)C2=CC=C(NC(/C=C/C3=CC(OC)=C(OC)C(OC)=C3)=O)C=C2

——

(-20℃)

With Ice Pack

≥ 2 years